Division of Cardiovascular Medicine

June 8, 2022

Genes and age studied as markers for higher death rate in those with atrial fibrillation

Younger patients with atrial fibrillation who had rare genetic variants associated with inherited cardiomyopathy and arrythmia syndromes were associated with a significantly higher rate of death than those without the variants, a Vanderbilt-led study has shown.

By Matt Batcheldor
June 2, 2022

VUMC renewed as a Comprehensive Hypertension Center

The Vanderbilt Comprehensive Hypertension Center has been awarded renewal of the American Heart Association’s Comprehensive Hypertension Center Certification,

By Matt Batcheldor
April 21, 2022

Drake, Freedman, Peebles elected AAP members

Vanderbilt’s Wonder Drake, MD, Jane Freedman, MD, and Stokes Peebles, MD, have been elected to membership in the Association of American Physicians (AAP), one of the nation’s most respected medical honor societies.

By Kathy Whitney
April 11, 2022

Peptides promote AFib arrhythmia

Peptide oligomers have detrimental metabolic effects and cause pro-arrhythmic electrophysiological changes in heart atria, suggesting they may contribute to atrial fibrillation.

By Leigh MacMillan
March 3, 2022

Chest Pain Center receives reaccreditation from ACC

Vanderbilt University Medical Center has been reaccredited as a Chest Pain Center with Primary Percutaneous Coronary Intervention (PCI) and Resuscitation.

By Kristin Smart
February 3, 2022

Team to study using probiotics to reduce heart disease risk

A Vanderbilt research team has received a $7 million grant from the National Institutes of Health (NIH) to understand how alcohol’s effect on the gut microbiome drives heart disease.

By Matt Batcheldor
November 18, 2021

Seven from VUMC among most highly cited researchers

Seven Vanderbilt faculty members have made this year’s list of scientists whose papers have been cited most frequently by other researchers.
By Bill Snyder
October 21, 2021

VUMC lauded for hypertrophic cardiomyopathy care

Vanderbilt University Medical Center was recently named a center of excellence for hypertrophic cardiomyopathy by the Hypertrophic Cardiomyopathy Association.
By Matt Batcheldor
October 7, 2021

Study finds genetic testing useful for young AFib patients

Vanderbilt research shows that genetic testing in patients with early-onset atrial fibrillation can identify variants associated with more serious cardiomyopathy and arrhythmia syndromes that may otherwise remain undiagnosed.
By Matt Batcheldor
October 7, 2021

Lindenfeld honored by Heart Failure Society of America

Vanderbilt's JoAnn Lindenfeld, MD, has received the Pioneer Award from the Heart Failure Society of America (HFSA) for being an innovator and pioneer in the field of heart failure.
By Matt Batcheldor
September 23, 2021

Stevenson receives HFSA Lifetime Achievement Award

Vanderbilt's Lynne Warner Stevenson, MD, has received  the Lifetime Achievement Award from the Heart Failure Society of America.
By Matt Batcheldor
September 8, 2021

New Clinician Spotlight: Jane Freedman

Jane Freedman, MD, has joined Vanderbilt University Medical Center as director of the Division of Cardiovascular Medicine and physician-in-chief of the Vanderbilt Heart and Vascular Institute.
By VUMC News and Communications
September 7, 2021

Regulators of fat cell metabolism

Vanderbilt researchers have discovered new details of the regulation of fat cell metabolism, findings that are important for combating obesity.
By Leigh MacMillan
1 … 3 4 5 6 7 … 12